4.5 Article

Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia

Related references

Note: Only part of the references are listed.
Article Psychiatry

Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders

Sherry Kit Wa Chan et al.

Summary: Research on the long-term development and early predictors of treatment-resistant schizophrenia (TRS) and clozapine-resistant TRS (CR-TRS) in patients with first-episode schizophrenia-spectrum disorders (FES) found that factors such as younger age of onset, poorer social adjustment, longer illness duration, and higher antipsychotic dose were associated with the development of TRS. Patients with CR-TRS had poorer outcomes compared to non-CR-TRS patients, suggesting the importance of early intervention and clozapine initiation in improving patient outcomes.

SCHIZOPHRENIA BULLETIN (2021)

Review Psychology, Clinical

Demographic and clinical variables associated with response to clozapine in schizophrenia: a systematic review and meta-analysis

Kira Griffiths et al.

Summary: The study investigated clinical and demographic factors associated with variation in clozapine response, finding that a shorter duration of illness, later illness onset, younger age at clozapine initiation, and fewer hospitalisations may be significantly associated with a better response to clozapine. The results suggest that prompt treatment with clozapine may lead to a better response compared to delayed treatment.

PSYCHOLOGICAL MEDICINE (2021)

Review Clinical Neurology

Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study

Parita Shah et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)

Review Genetics & Heredity

Consanguinity and Inbreeding in Health and Disease in North African Populations

Lilia Romdhane et al.

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 20, 2019 (2019)

Review Psychiatry

Clozapine pharmacogenomics: a review of efficacy, pharmacokinetics, and agranulocytosis

Kevin J. Li et al.

CURRENT OPINION IN PSYCHIATRY (2018)

Article Clinical Neurology

Factors associated with changes in hospitalisation in patients prescribed clozapine

Siobhan H. Gee et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2016)

Article Medicine, General & Internal

Antipsychotic medication in schizophrenia: a review

John Lally et al.

BRITISH MEDICAL BULLETIN (2015)

Editorial Material Biochemistry & Molecular Biology

Classics in Chemical Neuroscience: Clozapine

Cody J. Wenthur et al.

ACS CHEMICAL NEUROSCIENCE (2013)

Editorial Material Pharmacology & Pharmacy

Clozapine for the treatment of schizophrenia

Eric Fakra et al.

EXPERT OPINION ON PHARMACOTHERAPY (2012)

Article Psychiatry

The Premorbid Adjustment Scale Structured Interview (PAS-SI): Preliminary findings

Jonathan Rabinowitz et al.

SCHIZOPHRENIA RESEARCH (2007)

Article Pharmacology & Pharmacy

An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels

CH Ng et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)

Article Pharmacology & Pharmacy

Predictors of clinical outcome in schizophrenic patients responding to clozapine

MC Mauri et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)

Article Psychology, Clinical

Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia

DS Umbricht et al.

JOURNAL OF CLINICAL PSYCHIATRY (2002)

Review Psychiatry

When symptoms persist: Clozapine augmentation strategies

P Buckley et al.

SCHIZOPHRENIA BULLETIN (2001)